Clinical Trial Update: Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of oral recombinant human lactoferrin in patients with renal cell carcinoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Oral recombinant human lactoferrin (recombinant human lactoferrin)

Snippet

Sponsor: Agennix | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: COMPLETED